Journey Medical Corp reports results for the quarter ended December 31 - Earnings Summary

Journey Medical

26/03/2025 21:01

Journey Medical Corp DERM.OQ reported a quarterly adjusted loss of 15 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -12 cents.  The mean expectation of four analysts for the quarter was for a loss of 35 cents per share. Wall Street expected results to range from -83 cents to -15 cents per share.

Revenue fell 10.7% to $13.62 million from a year ago; analysts expected $14.21 million.

Journey Medical Corp's reported EPS for the quarter was 8 cents​.

The company reported quarterly net income of $1.52 million.

Journey Medical Corp shares had risen by 65.7% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts was unchanged in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for Journey Medical Corp is $10.00

This summary was machine generated from LSEG data March 26 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Dec. 31 2024
-0.35
-0.15
Beat
Sep. 30 2024
-0.15
-0.17
Missed
Jun. 30 2024
-0.14
-0.17
Missed
Mar. 31 2024
-0.23
-0.53
Missed